What is PrimaDiag?
PrimaDiag, a French enterprise established in 2007, is at the forefront of developing compact robotic platforms engineered for the swift automation of diverse protocols within molecular biology. Leveraging deep expertise in robotics, computer science, and biology, the company introduced its ACSIA product line in 2014. These solutions, complemented by the PrimaControllerII software, are designed to streamline complex tasks such as PCR preparation, nucleic acid purification, and NGS protocol execution, thereby minimizing user intervention. PrimaDiag's commitment lies in delivering robust, dependable, and cost-effective automation solutions precisely tailored to meet the varied requirements of its clientele.
How much funding has PrimaDiag raised?
PrimaDiag has raised a total of $423K across 1 funding round:
Angel/Seed
$423K
Angel/Seed (2009): $423K with participation from Investessor BA
Key Investors in PrimaDiag
Investessor BA
Investessor BA is a French non-profit business angel association dedicated to supporting startup entrepreneurs by connecting founders with experienced investors. They play a key role in fostering economic growth and business development across France.
What's next for PrimaDiag?
With its recent major strategic investment, PrimaDiag is poised for accelerated growth and further innovation in the life sciences automation sector. The company's focus on providing efficient and reliable robotic platforms for molecular biology protocols positions it to capitalize on the increasing demand for laboratory automation. Future developments are likely to center on expanding its product capabilities, enhancing software integration, and broadening its market reach, particularly within the European and global biotechnology markets. This capital infusion will be instrumental in scaling operations and solidifying its competitive edge.
See full PrimaDiag company page
